Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1305
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05212025 | Adavosertib and Gemcitabine in Advanced Pancreatic | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT00308178 | Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | ||
| NCT03661723 | Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma | ||
| NCT02375776 | Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention | ||
| NCT06805617 | A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers | ||
| NCT02816697 | Implementation of a System-level Tobacco Treatment Intervention | ||
| NCT00146562 | Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | ||
| NCT07147023 | Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication | ||
| NCT00856050 | Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma | ||
| NCT00085397 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT00153933 | Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT01829217 | Sunitinib in Never-Smokers With Lung Adenocarcinoma | ||
| NCT03683680 | Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers | ||
| NCT03065062 | Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors | ||
| NCT02268175 | Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | ||
| NCT00684411 | Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma | ||
| NCT05403801 | STAMP+CBT mHealth for Cancer Pain | ||
| NCT01239394 | Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma | ||
| NCT01890590 | A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | ||
| NCT00142467 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma | ||
| NCT00834093 | A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | ||
| NCT02164240 | Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST | ||
| NCT01566890 | Microvascular Blood Flow in Sickle Cell Anemia | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT05721248 | STOP-HER2: Stopping Trastuzumab in HER2+ MBC | ||
| NCT02666378 | Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer | ||
| NCT05407441 | Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors | ||
| NCT03291951 | FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study | ||
| NCT00126672 | RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS | ||
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | ||
| NCT03681483 | RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer | ||
| NCT00020670 | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT02326974 | T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA | ||
| NCT04906096 | Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL | ||
| NCT04290546 | CIML NK Cell in Head & Neck Cancer | ||
| NCT04691297 | Digitally Enhanced Smoking Cessation for High Risk Smokers | ||
| NCT02129686 | A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients | ||
| NCT01516190 | The Preoperative Health & Body Study | ||
| NCT00113646 | Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies | ||
| NCT02657343 | An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. | ||
| NCT03637543 | Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer | ||
| NCT03636503 | Rituximab + Immunotherapy in Follicular Lymphoma | ||
| NCT00483262 | Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma | ||
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00053976 | Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease | ||
| NCT07624513 | Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT02675959 | Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease | ||
| NCT00483223 | Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response | ||
| NCT03447886 | Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds |
